The Evolution of Prognostic Factors in Multiple Myeloma
Joint Authors
Aljurf, Mahmoud
Hanbali, Amr
Hassanein, Mona
Rasheed, Walid
Alsharif, Fahad
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-02-21
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Multiple myeloma (MM) is a heterogeneous hematologic malignancy involving the proliferation of plasma cells derived by different genetic events contributing to the development, progression, and prognosis of this disease.
Despite improvement in treatment strategies of MM over the last decade, the disease remains incurable.
All efforts are currently focused on understanding the prognostic markers of the disease hoping to incorporate the new therapeutic modalities to convert the disease into curable one.
We present this comprehensive review to summarize the current standard prognostic markers used in MM along with novel techniques that are still in development and highlight their implications in current clinical practice.
American Psychological Association (APA)
Hanbali, Amr& Hassanein, Mona& Rasheed, Walid& Aljurf, Mahmoud& Alsharif, Fahad. 2017. The Evolution of Prognostic Factors in Multiple Myeloma. Advances in Hematology،Vol. 2017, no. 2017, pp.1-11.
https://search.emarefa.net/detail/BIM-1121839
Modern Language Association (MLA)
Hanbali, Amr…[et al.]. The Evolution of Prognostic Factors in Multiple Myeloma. Advances in Hematology No. 2017 (2017), pp.1-11.
https://search.emarefa.net/detail/BIM-1121839
American Medical Association (AMA)
Hanbali, Amr& Hassanein, Mona& Rasheed, Walid& Aljurf, Mahmoud& Alsharif, Fahad. The Evolution of Prognostic Factors in Multiple Myeloma. Advances in Hematology. 2017. Vol. 2017, no. 2017, pp.1-11.
https://search.emarefa.net/detail/BIM-1121839
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1121839